Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Warrior Met Coal Inc (HCC)

Warrior Met Coal Inc (HCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Hanna Announces Private Placement and Results of Shareholders' Meeting

TORONTO, ON / ACCESS Newswire / December 11, 2025 / Hanna Capital Corp. (the "Corporation") is pleased to announce that it intends to raise gross proceeds of up to $170,000 through a non-brokered private...

HCC : 89.16 (-0.04%)
Warrior Reports Third Quarter 2025 Results and Updates Outlook

Commences longwall operations at transformational Blue Creek mine, eight months ahead of schedule and on budget Raises full year outlook to reflect strong operational...

HCC : 89.16 (-0.04%)
Warrior Announces Regular Quarterly Cash Dividend

Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today announced that its board of directors has approved a regular quarterly cash dividend of $0.08 per share to be paid on November...

HCC : 89.16 (-0.04%)
Warrior Announces Regular Quarterly Cash Dividend

Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today announced that its board of directors has approved a regular quarterly cash dividend of $0.08 per share to be paid on November...

HCC : 89.16 (-0.04%)
Move Over, Magnificent 7: This 1 Rare Earth ETF Is Winning Over Wall Street Now

The SPDR S&P Metals & Mining ETF is up nearly 75% in 2025, outperforming the S&P 500 and tech giants like Nvidia as investors rotate into real assets; tariffs, industrial demand, and rising metal prices...

AA : 53.63 (-0.04%)
NVDA : 188.61 (-0.32%)
AAPL : 273.81 (+0.53%)
BTU : 30.79 (-1.35%)
MP : 54.54 (+0.61%)
HL : 19.83 (-2.32%)
CDE : 18.72 (-1.94%)
$SPX : 6,932.05 (+0.32%)
CNR : 89.11 (-0.25%)
HCC : 89.16 (-0.04%)
MSFT : 488.02 (+0.24%)
XME : 107.87 (-0.13%)
US rejects bid to lease coal from public lands in Utah as sales in western states fall flat

U.S. officials have rejected a mining company’s bid for more than 6 million tons of coal beneath a national forest in Utah

HCC : 89.16 (-0.04%)
Warrior Sets Date for Third Quarter 2025 Earnings Announcement and Investor Conference Call

Warrior Met Coal, Inc. (“Warrior” or NYSE: HCC) today announced that it will hold its third quarter 2025 investor conference call at 4:30 p.m. ET on Wednesday, November 5, 2025. Warrior will release...

HCC : 89.16 (-0.04%)
RBC Capital Keeps Their Hold Rating on Warrior Met Coal (HCC)

RBC Capital analyst Sam Crittenden maintained a Hold rating on Warrior Met Coal on October 8. The company’s shares closed yesterday at $65.53.Elevate Your Investing Strategy: Take advantage of TipRanks...

HCC : 89.16 (-0.04%)
Hanna Completes Debt Conversion & Private Placement & Announces Changes to Board

TORONTO, ON / ACCESS Newswire / September 19, 2025 / Hanna Capital Corp. (the "Corporation") announces, that further to its press releases dated June 30 and September 15, 2025, that it has issued an aggregate...

HCC : 89.16 (-0.04%)
Hanna Updates Debt Conversion and Private Placement

TORONTO, ON / ACCESS Newswire / September 15, 2025 / Hanna Capital Corp. (the "Corporation") announces, that further to its press release dated June 30, 2025, the terms of the previously announced debt...

HCC : 89.16 (-0.04%)

Barchart Exclusives

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar